The long-simmering feud between Elon Musk and his former partners at OpenAI has finally reached the courtroom, marking a pivotal moment for the artificial intelligence industry. On Monday, jury selection concluded in an Oakland federal court, setting the stage for a high-stakes legal battle presided over by Judge Yvonne Gonzalez Rogers. The trial pits the world’s wealthiest man against Sam Altman and Greg Brockman, the leaders of the organization Musk helped found in 2015.
At the heart of the dispute is Musk’s allegation that OpenAI betrayed its founding mission to develop artificial intelligence for the benefit of humanity rather than profit. While Musk exited the board in 2018 and later founded the competitor xAI, he claims that the transition of OpenAI into a multi-tiered corporate structure constitutes a breach of charitable trust. The plaintiff's side initially sought $134 billion in damages for "unjust enrichment," though legal strategy has since shifted toward redirecting those funds back into OpenAI’s non-profit arm.
The trial is structured in two distinct phases: a liability phase to determine if rules were broken, followed by a remedy phase to decide on damages or structural changes. Crucially, the jury’s role is limited to an advisory capacity during the liability phase, leaving Judge Gonzalez Rogers with the ultimate authority over the final ruling. This procedural nuance could be decisive, as public sentiment toward Musk’s polarizing persona has already become a point of contention during jury selection.
This legal reckoning arrives as both parties navigate massive capital maneuvers in the private markets. Musk is currently preparing for a potentially record-breaking IPO for SpaceX, which recently merged with his AI venture, xAI. Simultaneously, OpenAI is reportedly gearing up for its own public debut later this year, with the combined valuation of these two rival empires exceeding $2 trillion. The outcome of this trial may not only redefine the leadership of OpenAI but also set a legal precedent for how non-profit missions are protected in the age of commercialized AGI.